Mikko J. Loukovaara - Publications

Tumor Grade in Molecularly Defined Endometrial Carcinoma: Prognostic Implications of the ESGO-ESTRO-ESP 2025 Guidelines.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: April 10, 2026

Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 24, 2026

Evolution of lymph node assessment in endometrial carcinoma: a cohort study within the 2025 European prognostic classification.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 24, 2025

Evaluation of the new European risk classification for endometrial carcinoma: a cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 31, 2025

Explainable machine learning for preoperative relapse prediction in molecularly stratified endometrial cancer: A single-center finnish cohort study.

Journal: Computational and structural biotechnology journal

Published: October 27, 2025

Estrogen Receptor, GATA-3, TTF-1, and KRAS in Endometrial Carcinoma of No Specific Molecular Profile: Prognostic or Diagnostic Markers?

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: October 06, 2025

Distinct clinical outcomes according to molecular subgroups in relapsed endometrial carcinoma: A cohort study.

Journal: Gynecologic oncology

Published: July 09, 2025

Molecular subgroup-specific prognostic value of semiquantitative lymphovascular space invasion in early-stage endometrioid endometrial cancer.

Journal: Gynecologic oncology

Published: March 21, 2025

PPP2R1A mutation status as a predictive and prognostic factor in molecularly characterized endometrial carcinoma: a cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 02, 2025

Comparative analysis of European guideline-based clinicopathological risk groups and the International Federation of Gynecology and Obstetrics staging system for endometrial cancer.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: January 04, 2025

Clinicopathologic stratification demonstrates survival differences between endometrial carcinomas with mismatch repair deficiency and no specific molecular profile: a cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 23, 2024

HER2 amplification and HER2 low expression in endometrial carcinoma: prevalence across molecular, histological and clinicopathological risk groups.

Journal: BJC reports

Published: September 11, 2024